Skip to content
2000
Volume 6, Issue 2
  • ISSN: 1574-891X
  • E-ISSN: 2212-4071

Abstract

Thioridazine is a phenothiazine drug which has previously been extensively used for its antipsychotic properties as it is associated with a low risk of extra-pyramidal side-effects. There is good evidence to suggest that, in common with other phenothiazine drugs, thioridazine has important anti-microbial activity and is a potential candidate for development as an anti-microbial drug against multi-resistant organisms, including drug-resistant strains of Mycobacterium tuberculosis. The clinical pharmacology and toxicity profile of thioridazine are reviewed in this article and the implications for future drug development along with the patent are discussed.

Loading

Article metrics loading...

/content/journals/pri/10.2174/157489111796064588
2011-05-01
2025-08-19
Loading full text...

Full text loading...

/content/journals/pri/10.2174/157489111796064588
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test